Quest Diagnostics (DGX)

Cost of Revenue

$7.92B

TTM · Period ending: · USD

DGX logo

DGX Cost of Revenue

Latest reported$7.92B
DGX TTM Cost of Revenue ($875.50M → $7.92B)
High-resolution chart · PNG

DGX cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Quest Diagnostics Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
7,916,000,000
7,728,000,000
7,530,000,000
7,366,000,000
7,237,000,000
7,047,000,000
6,822,000,000
6,628,000,000
6,413,000,000
6,277,000,000
6,230,000,000
6,195,000,000
6,222,000,000
6,299,000,000
6,364,000,000
6,450,000,000
6,593,000,000
6,645,000,000
6,599,000,000
6,579,000,000
6,594,000,000
6,504,000,000
6,160,000,000
5,804,000,000
5,335,000,000
5,019,000,000
5,063,000,000
5,037,000,000
5,008,000,000
4,966,000,000
4,944,000,000
4,926,000,000
4,885,000,000
4,853,000,000
4,780,000,000
4,719,000,000
4,685,000,000
4,652,000,000
4,637,000,000
4,616,000,000
4,606,000,000
4,611,000,000
4,638,000,000
4,657,000,000
4,691,000,000
4,707,000,000
4,699,000,000
4,637,000,000
4,504,000,000
4,414,500,000
4,334,200,000
4,325,000,000
4,346,600,000
4,347,800,000
4,364,600,000
4,389,300,000
4,394,067,000
4,420,967,000
4,414,867,000
4,395,367,000
4,398,438,000
4,373,338,000
4,347,838,000
4,317,238,000
4,307,039,000
4,313,039,000
4,334,351,000
4,321,440,000
4,292,126,000
4,267,749,000
4,251,018,000
4,256,156,000
4,257,954,000
4,211,429,000
4,096,690,000
3,969,848,000
3,846,539,000
3,753,676,000
3,721,366,000
3,712,565,000
3,664,706,000
3,537,991,000
3,400,237,000
3,257,335,000
3,143,210,000
3,084,614,000
3,044,131,000
3,001,330,000
2,950,122,000
2,912,878,000
2,857,807,000
2,768,623,000
2,681,718,000
2,595,613,000
2,522,747,000
2,432,388,000
2,350,645,000
2,261,134,000
2,180,267,000
2,117,329,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.